Eli Lilly and Co (USD)
LLY
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range138.70 | 141.99
52-Wk Range101.36 | 142.25
Last Close139.07
Mkt Cap (m)133,525.39
Dividend yield1.86%
ISINUS5324571083
Volume3,183,268
Exchange VenueNYS

Company Profile

Eli Lilly and Co is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products.

Key Information
Price/Earning30.90
Price/Book39.53
Price/Sales5.37
P/CF30.96
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-
Debt/Equity-

Documents

Prospectus
en 30/10/2019
Annual Report
en 31/12/2018

Financials

Income Statement
USD201420152016201720182019
Revenue (m)19,61619,95921,22222,87124,556-
Operating Income (m)3,3293,5923,8714,9316,429-
Net Income (m)2,3912,4082,738-2043,232-
Basic EPS2.232.272.59-0.193.14-
Avg. Diluted Shares Outstanding (m)1,0741,0661,0621,0521,034-
Balance Sheet
USD201420152016201720182019
Current Assets (m)12,18012,57415,10119,20220,550-
Non Current Assets (m)24,99822,99523,70525,77923,359-
Total Assets (m)37,17835,56938,80644,98143,908-
Current Liabilities (m)11,2088,23010,98714,53611,888-
Total Liabilities (m)------
Total Equity (m)15,37314,57114,00811,5929,829-
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)4,3672,7734,8515,6165,525-
Capital Expenditure (m)-1,566-1,626-1,092-2,164-3,018-
Figures are quoted in USD unless stated otherwise
0.00 (0.00%)
$
139.07
Last Price